PAA 0.00% 19.5¢ pharmaust limited

Ann: PharmAust to present at Emerging ASX Gems Conference, page-47

  1. 273 Posts.
    lightbulb Created with Sketch. 366
    Thanks Pete.

    Upon reading the article it seems to me that we could equally qualify for Orphan Drug Designation as well as Breakthrough Therapy.

    I'd like to know if there is a reason not to pursue both avenues.

    If we achieve FDA approval for Breakthrough Therapy then surely an interested party would be eager to advance a proposal to PAA


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.55M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.